Cross-linking of 4-1BB activates TCR-signaling pathways in CD8+ T lymphocytes

Journal of Immunology

Volumn 174, Issue 4, 2005, Pages 1898-1905

  Nam, Kyung Ok ^b   Kang, Hyun ^b   Shin, Su Mi ^b   Cho, Kwang Hyun ^c   Kwon, Byoungsuk ^b   Kwon, Byoung S ^b   Kim, Sung Jin ^a   Lee, Hyeon Woo ^a,b  

^a Kyung Hee University   (South Korea)

^b University of Ulsan   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CD137 ANTIGEN; CD3 ANTIGEN; CD8 ANTIGEN; I KAPPA B ALPHA; METHYL BETA CYCLODEXTRIN; PHOSPHOLIPASE C GAMMA; PHOSPHOPROTEIN; PROTEIN KINASE C THETA; PROTEIN KINASE LCK; PROTEIN SH2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; LIPID RAFT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 13544252809     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.4.1898     Document Type: Article

References (34)

1. Lafferty, K. J., and J. Woolnough. 1977. The origin and mechanism of the allograft reaction. Immunol. Rev. 35:231.
2. June, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindstein, and C. B Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell Biol. 7:4472.
3. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
4. Mueller, D. L., M. K. Jenkins, and R. H. Schwarz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
5. Weinberg, A. D., A. T. Vella, and M. Croft. 1998. Ox-40: life beyond the effector T cell stage. Semin. Immunol. 10:471.
6. Watts, T. H., and M. A. DeBenedette. 1999. T cell costimulatory molecule other than CD28. Curr. Opin. Immunol. 11:286.
7. Gravestein, L. A., and J. Borst. 1998. Tumor necrosis factor receptor family members in the immune system. Semin. Immunol. 10:423.
8. Jang, I. K., Z. H. Lee, Y.-J. Kim, and B. S. Kwon. 1998. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-κB. Biophys. Biochem. Res. Commun. 242:613.
9. Arch, R. H., and C. B. Thompson. 1998. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor-κB. Mol. Cell. Biol. 18:558.
10. Saoulli, K., S. Y. Lee, J. L. Cannons, W. C. Yeh, A. Santana, M. D. Goldstein, N. Bangia, M. A. DeBenedette, T. W. Mak, Y. Choi, and T. H. Watts. 1998. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J. Exp. Med. 187:1849.
11. Cannons, J. L., Y. Choi, and T. H. Watts. 2000. Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response. J. Immunol. 165:6193.
12. Vinay, D. S., and B. S. Kwon. 1998. Role of 4-1BB in immune regulation. Semin. Immunol. 10:481.
13. Kwon, B., C. H. Moon, S. K. Seo, and B. S. Kwon. 2000. 4-1BB: still in the midst of darkness. Mol. Cells 30:119.
14. Shuford, W. W., K. Klussman, D. D. Tritchler, D. T. Loo, J. Chalupny, A. W. Siadak, T. J. Brown, J. Emswiler, H. Raecho, C. P. Larsen, et al. 1997. 4-1BB costimulatory signals preferentially induce CD8 T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186:47.
15. Tan, J. T., J. Ha, H. R. Cho, C. Tucker-Burden, R. C. Hendrix, R. S. Mittler, T. C. Pearson, and C. P. Larsen. 2000. Analysis of expression and function of the costimulatory molecule 4-1BB in alloimmune responses. Transplantation 70:175.
16. Melero, I., W. W. Shuford, S. A. Newby, A. Aruffo, J. A. Ledbetter, K. E. Hellstrom, R. S. Mittler, and L. Chen. 1997. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med. 3:682.
17. L and Bfl-1. J. Immunol. 169:4882.
18. kip1. Eur. J. Immunol. 33:2133.
19. Lee, H.-W., K.-O. Nam, S. K. Seo, Y. H. Kim, H. Kang, and B. S. Kwon. 2003. 4-1BB cross-linking enhances the survival and cell cycle progression of CD4 T lymphocytes. Cell. Immunol. 223:143.
20. Werlen, G., and E. Palmer. 2002. The T-cell signalosome: a dynamic structure with expanding complexity. Curr. Opin. Immunol. 14:299.
21. Kim, M. J., E. Kim, S. H. Ryu, and P. G. Suh. 2000. The mechanism of phospholipase C-γl regulation. Exp. Mol. Med. 32:101.
22. Takahashi, C., R. S. Mittler, and A. T. Vella. 1999. 4-1BB is a bona fide CD8 T cell survival signal. J. Immunol. 162:5037.
23. Cooper, D., P. Bansal-Pakala, and M. Croft. 2002. 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but not contributes to the development of cytotoxicity. Eur. J. Immunol. 32:521.
24. Cannons, J. L., P. Lau, B. Ghumman, M. A. DeBenedette, H. Yagita, K. Okumura, and T. H. Watts. 2001. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J. Immunol. 167:1313.
25. Mittler, R. S., T. S. Bailey, K. Klussman, M. D. Trailsmith, and M. K. Hoffmann. Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy. J. Exp. Med. 190:1535.
26. Blazar, B. R., B. S. Kwon, A. Panoskaltsis-Mortari, K. B. Kwak, J. J. Peschon, and P. A. Taylor. 2001. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients. J. Immunol. 166:3174.
27. Seko, Y., N. Takahashi, H. Oshima, O. Shimozato, H. Akiba, K. Takeda, T. Kobata, H. Yagita, K. Okumura, M. Azuma, and R. Nagai. 2001. Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by coxsackievirus B3. J. Pathol. 195:593.
28. Sun, Y., X. Lin, H. M. Chen, Q. Wu, S. K. Subudhi, L. Chen, and Y. X. Fu. 2002. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J. Immunol. 168:1457.
29. Ye, Z., I. Hellstrom, M. Hayden-Ledbetter, A. Dahlin, J. A. Ledbetter, and K. E. Hellstrom. 2002. Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB. Nat. Med. 8:343.
30. Salazar, E. P., and E. Rozengurt. 1999. Bombesin and platelet-derived growth factor induce association of endogenous focal adhesion kinase with Src in intact Swiss 3T3 cells. J. Biol. Chem. 274:28371.
31. Marwali, M. R., J. Rey-Ladino, L. Dreolini, D. Shaw, and F. Takei. 2003. Membrane cholesterol regulates LFA-1 function and lipid raft heterogeneity. Blood 102:215.
32. Kim, Y. Z., P. L. Mantel, C. H. June, S. H. Kim, and B. S. Kwon. 1999. 4-1BB costimulation promotes human T cell adhesion to fibronectin. Cell. Immunol. 192:13.
33. Chalupny, N. J., R. Peach, D. Hollenbaugh, J. A. Ledbetter, A. G. Farr, and A. Aaruffo. 1992. T-cell activation molecule 4-1BB binds to extracellular matrix proteins. Proc. Natl. Acad. Sci. USA 89:10360.
34. Vidalain, P. O., O. Azocar, C. Servet-Delprat, C. Rabourdin-Combe, D. Gerlier, and S. Manie. 2000. CD40 signaling in human dendritic cells is initiated within membrane rafts. EMBO J. 19:3304.